Myasthenia Gravis
MYASTHENIA GRAVIS
Overview
- Chronic autoimmune disorder characterized by muscle weakness.
- Improves with rest.
Pathophysiology
- Antibodies destroy acetylcholine (ACh) receptors.
- Loss of voluntary muscle strength due to inability of ACh to stimulate muscle contraction.
Etiology
- Unknown causes; potential associations include autoimmune mechanisms and thymus disorders.
- Possible viral origin.
- More common in women aged 30-39 and men over 60.
- Two types: Ocular and generalized.
Signs and Symptoms
- Progressive muscle weakness, particularly with activity.
- Common symptoms include:
- Ptosis
- Fatigue
- Difficulty chewing, swallowing, speaking
- Breathing difficulties
- Mask-like facial expression
- Symptoms show remissions and exacerbations.
Diagnostic Testing
- Physical exam
- Chest radiography
- Electromyography (EMG)
- Acetylcholine receptor antibody test (AChR)
- Tensilon test (inject tension to assess worsening ptosis).
Medical Management
- Thymectomy: Decreases AChR antibodies.
- Anticholinergics: Neostigmine (Prostigmin), Pyridostigmine (Mestinon).
- Immunosuppressants: Prednisone, Azathioprine (Imuran).
- Plasmapheresis for severe respiratory distress.
Complications
- Myasthenic Crisis: weakness leading to respiratory failure due to too little medication.
- Cholinergic Crisis: symptoms include salivation, lacrimation, urinary incontinence, diarrhea due to too much medication (SLUDGE acronym).
Nursing Interventions
- Fall prevention
- Support ventilation and monitor respiratory status
- Communication assistance
- Medication administration and monitoring
- Monitor for myasthenic or cholinergic crisis.
Patient Education
- Avoid triggers for exacerbations:
- Stress
- Strenuous exercise
- Infections
- Temperature extremes
- Electrolyte imbalances
- Be cautious with medications that block neuromuscular junction actions.